Cvs Pharmacy #07013 is an authorized DME supplier for medicare equipments and products.
Cvs Pharmacy #07013 is a Pharmacy in Weaverville, North Carolina. This pharmacy is owned and operated by North Carolina Cvs Pharmacy Llc. It is located at 121 Monticello Rd, Weaverville and it's customer support contact number is 828-645-5802. The authorized person of Cvs Pharmacy #07013 is Susan Colbert who is Director, Payer Relations of the pharmacy and his contact number is 401-770-2751. Active license number of Cvs Pharmacy #07013 is 6805 for Pharmacy in North Carolina. Cvs Pharmacy #07013 accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Cvs Pharmacy #07013 is a facility used by pharmacists for the compounding and dispensing of medicinal preparations and other associated professional and administrative services. A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located.
Pharmacy Details:
Cvs Pharmacy #07013 type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Cvs Pharmacy #07013
Type:
Pharmacy
Location:
121 Monticello Rd, Weaverville, North Carolina, 28787-8931
Phone:
828-645-5802
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Susan Colbert
Position:
Director, Payer Relations
Contact Number:
401-770-2751
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1679676365
NPI Enumeration Date:
07 Sep, 2006
NPI Last Update On:
05 Mar, 2012
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Cvs Pharmacy #07013 are as mentioned below.
Specialization
License Number
State
Status
Pharmacy
6805
North Carolina
Primary
Durable Medical Equipment & Medical Supplies
Secondary
Community/Retail Pharmacy
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
3424758
Other
Other Id Number-commercial Number
Medicare Enrollment:
Cvs Pharmacy #07013 is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
9133200017
O20110511000545
North Carolina Cvs Pharmacy Llc.
DME SUPPLIER - PHARMACY
Products Available:
Cvs Pharmacy #07013 has following products available for sale under medicare.
Products
Blood Glucose Monitors & Supplies: Mail Order
Blood Glucose Monitors & Supplies: Non-mail Order
Canes & Crutches
Commodes, Urinals, & Bedpans
Enteral Equipment And/or Supplies
Enteral Nutrients
Heat & Cold Applications
Nebulizer Equipment & Supplies
Ostomy Supplies
Parenteral Equipment And/or Supplies
Parenteral Nutrients
Surgical Dressings
Urological Supplies
Walkers
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1 Cvs Dr, Box 1075 Woonsocket, Rhode Island
Zip:
02895-6146
Phone Number:
401-765-1500
Fax Number:
--
Patients can reach Cvs Pharmacy #07013 at 121 Monticello Rd, Weaverville, North Carolina or can call on customer care at 828-645-5802.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.